https://www.selleckchem.com/products/torin-1.html Cytochrome P450 (CYPs) participate in the mechanisms of cardiovascular disease. The purpose of this research was to evaluate the contributions of CYP24A1 variants to coronary heart disease (CHD) among the Chinese Han population. This study included 505 CHD cases and 508 controls. Four variants of CYP24A1 (rs2762934, rs1570669, rs6068816 and rs2296241) were chosen and genotyped by the Agena MassARRAY system among the Chinese population. The linkage between CYP24A1 variants and CHD risk were assessed by logistic regression to compute the odds ratio (OR) and 95% confidence interval (CI). Then, multifactor dimensionality reduction (MDR) was applied to analyze the interactions of CYP24A1 variants. The results of this study showed that CYP24A1 rs6068816 significantly enhanced CHD risk in multiple genetic models (allele P = 0.014; codominant P = 0.015; dominant P = 0.043; recessive P = 0.040; additive P = 0.013), whereas rs2296241 was likely to protect individuals from CHD (codominant P = 0.019; recessive P = 0.013; additive P = 0.033). Stratification analysis revealed that CYP24A1 polymorphisms had strong relationships with CHD risk that were dependent on age, sex, Gensini grade and smoking status (P < 0.05). Moreover, a four-locus model (rs2762934, rs1570669, rs6068816 and rs2296241) had significant impact on CHD risk in MDR analysis. It revealed that CYP24A1 variants were significantly linked with CHD susceptibility in the Chinese population. It revealed that CYP24A1 variants were significantly linked with CHD susceptibility in the Chinese population. China carried out a comprehensive drug price reform (CDPR) in 2017 to control the growing expense of drug effectively and reduce the financial burden of inpatients. However, early studies in pilot regions found the heterogeneity in the effectiveness of CDPR from different regions and other negative effects. This study aimed to evaluate the effects of the reform on medical e